Biotech News

Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock

Neuronetics (STIM)NeuroneticsFinancing

MALVERN, Pa., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced the pricing of its previously announced underwritten public offering of its common stock, comprised of 18,750,000 shares of common stock at a public offering price of $1.60 per share.

Related news

Neuronetics

Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders. It combines a proprietary treatment system with a national network of clinics that directly delivers therapy. NeuroStar Advanced Therapy NeuroStar uses...

Recent company news

Stock data

Close
1.24 USD
Market cap
108.56M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States